Delivery Order SPE2DR25D1051-SPE2DR26F40D1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $11,562.78. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, utilizing no set-aside designation and awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Jardiance 10 mg tablets (90-count units) valued at $1,579.10, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $2,406.07. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, issued under a non-competitive set-aside arrangement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (quantity: 90) valued at $24,553.33 on February 3, 2026, with an ultimate completion date of February 4, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded on a full and open basis. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This contract, valued at $9,013.99, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the pharmaceutical distributor. The order is scheduled for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $5,100.30. This firm fixed-price delivery order, with an ultimate completion date of December 23, 2025, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The award was made on a competitive, non-set-aside basis and will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $7,763.89. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. AmerisourceBergen Drug Corp, a subsidiary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- SPE2DR25D1051Indefinite Delivery Contract
- SPE2DR25D1051-SPE2DR26F40D1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $4,516.15. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. AmerisourceBergen Drug Corp is the subsidiary operating under its parent company Cencora, Inc., which does business as AmerisourceBergen. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime indefinite delivery vehicle running through December 2026 that provides comprehensive pharmaceutical support to military healthcare programs worldwide. The IDC encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Jardiance, a diabetes management medication, aligns with AmerisourceBergen's established portfolio of pharmaceutical deliveries to federal military and veteran healthcare systems through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 2/3/26 |